Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo

Eitemau Tebyg

• Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
  gan: Shrimanker, R, et al.
  Cyhoeddwyd: (2017)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  gan: Howell, I, et al.
  Cyhoeddwyd: (2024)
• Exacerbations of severe asthma in patients treated with mepolizumab
  gan: Shrimanker, R, et al.
  Cyhoeddwyd: (2018)
• Mepolizumab and exacerbations of refractory eosinophilic asthma.
  gan: Haldar, P, et al.
  Cyhoeddwyd: (2009)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  gan: Imran Howell, et al.
  Cyhoeddwyd: (2024-07-01)